Skip to content

Atovaquone

Antimalarial — ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Also known as: 566C80, mepron

OfpFDA approvedOrphan designationATC P01AX06ATC P01BB51

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Atovaquone is an ofp drug in the Antimalarial class catalogued in DrugCentral. It was first approved by the FDA in 1992. DrugCentral lists 7 molecular targets, including ABCG2, Dihydroorotate dehydrogenase and Dhodh. Recorded indications include Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention, Falciparum malaria, Plasmodium Falciparum Malaria Prevention and Pneumocystis Carinii Pneumonia Prevention.

  • Approval status: ofp (first approved 1992 by the FDA).
  • Drug class: Antimalarial; Antiprotozoal.
  • Molecular targets: ABCG2, Dihydroorotate dehydrogenase, Dhodh and DHODH (7 listed in DrugCentral).
  • Indications: Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention, Falciparum malaria, Plasmodium Falciparum Malaria Prevention, Pneumocystis Carinii Pneumonia Prevention and Pneumocystosis jiroveci pneumonia.
  • ATC code: P01AX06 (Other agents against amoebiasis and other protozoal diseases).
  • Molecular formula: C22H19ClO3; molecular weight 366.84 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (5)

  • Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention
  • Falciparum malaria
  • Plasmodium Falciparum Malaria Prevention
  • Pneumocystis Carinii Pneumonia Prevention
  • Pneumocystosis jiroveci pneumonia

Off-label uses (5)

  • Babesiosis
  • Toxoplasmosis
  • Toxoplasmosis associated with acquired immunodeficiency syndrome
  • Toxoplasmosis Prevention
  • Vivax malaria

Contraindications (8)

  • Acute nephropathy
  • Anemia due to enzyme deficiency
  • Chronic diarrhea
  • Disease of liver
  • Hepatic failure
  • Hyperglycemia
  • Malabsorption States
  • Vomiting

Mechanism & targets

Established pharmacologic classAntimalarial; Antiprotozoal

Molecular targets (7)

TargetGeneActionActivity
ATP-binding cassette sub-family G member 2ABCG2unknownIC50 6.64
Dihydroorotate dehydrogenase—unknownIC50 6.37
Dihydroorotate dehydrogenase (quinone), mitochondrialDhodhunknownIC50 6.15
Dihydroorotate dehydrogenase (quinone), mitochondrialDHODHunknownIC50 5.03
Dihydroorotate dehydrogenasedhodunknownKi 4.57
Cytochrome bMT-CYBinhibitor—
Ubiquinol-cytochrome-c reductase complex core protein I, mitochondrial—unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1992-11-25FDA——Yes

ATC classification

ATC codeTherapeutic hierarchy
P01AX06ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES › Other agents against amoebiasis and other protozoal diseases
P01BB51ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Biguanides

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Nocardiosis287.6
Pneumocystis jirovecii pneumonia198.1
Pancytopenia187.7
Malaria174.4
Thrombocytopenia173.0
Cytokine release syndrome165.7
Pulmonary nocardiosis163.6
Neutropenia151.3
Thrombotic microangiopathy150.9
Hepatic cytolysis149.6
Immune reconstitution inflammatory syndrome149.3
IVth nerve paralysis134.8

Chemical structure

Molecular formulaC22H19ClO3
Molecular weight366.84 g/mol
CAS number95233-18-4
InChIKeyKUCQYCKVKVOKAY-CTYIDZIISA-N
PubChem CID74989
OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Atovaquone used for?

DrugCentral lists the following indications for Atovaquone: Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention, Falciparum malaria, Plasmodium Falciparum Malaria Prevention, Pneumocystis Carinii Pneumonia Prevention and Pneumocystosis jiroveci pneumonia.

How does Atovaquone work?

Its molecular targets in DrugCentral include ABCG2, Dihydroorotate dehydrogenase, Dhodh and DHODH.

When was Atovaquone first approved?

Atovaquone was first approved by the FDA in 1992.

What drug class does Atovaquone belong to?

Atovaquone is in the Antimalarial class.

What is the chemical formula of Atovaquone?

Atovaquone has the molecular formula C22H19ClO3 and a molecular weight of 366.84 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1992-11-25
AgencyFDA
Targets7
Indications5
FormulaC22H19ClO3
DrugCentral ID258
Interactive profile